Chronic Myelocytic Leukemia in a Juvenile Rhesus Macaque (Macaca mulatta)

Contemporary Topics in Laboratory Animal Science

Volumn 40, Issue 4, 2001, Pages 44-48

  Krugner Higby, Lisa A ^a   Gendron, Annette ^a   Laughlin, Nellie K ^a   Luck, Melissa ^a   Scheffler, Joan ^b   Phillips, Brenda ^c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEAD;

ANIMAL; ANIMAL DISEASE; ARTICLE; CHRONIC MYELOID LEUKEMIA; EXPERIMENTAL ANIMAL; FEMALE; MACACA; POLYMERASE CHAIN REACTION;

ANIMALS; ANIMALS, LABORATORY; FEMALE; LEAD; LEUKEMIA, MYELOID, CHRONIC; MACACA MULATTA; POLYMERASE CHAIN REACTION;

EID: 0035406019     PISSN: 10600558     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Holscher, M. A., L. D. Sly, J. B. Cousar, et al. 1984. Monocytic leukemia in a greater bushbaby (Galago crassicaudatus argentatus). Lab. Anim. Sci. 34:619-620.
2. Bennett, B. T., F. Z. Beluhan, and S. C. Sarpel. 1981. Acute myelomonocytic leukemia in a capuchin monkey (Cebus apella). Lab. Anim. Sci. 31:519-521.
3. Gardner, M. B., G. Esra, M. J. Cain, et al. 1978. Myelomonocytic leukemia in an orangutan. Vet. Pathol. 15:667-670.
4. Chalifoux, L. V., and N. W. King. 1983. Eosinophilic myelocytoma in an owl monkey (Aotus trivirgatus). Lab. Anim. Sci. 33:189-191.
5. DePaoli, A., D. O. Johnson, and N. W. Noll. 1973. Granulocytic leukemia in whitehanded gibbons. J. Am. Vet. Med. Assoc. 163:624-628.
6. Lowenstine, L. J., N. W. Lerche, J. L. Yee, et al. 1992. Evidence for a lentiviral eitiology in an epizootic of immune deficiency and lymphoma in stump-tailed macaques (Macaca arctoides). J. Med. Primatol. 21:1-14.
7. Fultz, P. N., T. McGinn, I. C. Davis, et al. 1999. Coinfection of macaques with simian immunodeficiency virus and simian T cell leukemia virus type I: effects on virus burdens and disease progression. J. Infect. Dis. 179:600-611.
8. Traina-Dorge, V., J. Blanchard, L. Martin, et al. 1992. Immunodeficiency and lymphoproliferative disease in an African green monkey dually infected with SIV and STLV-I. AIDS Res. Hum. Retroviruses 8:97-100.
9. Schatzl, H., M. Tshikolva, D. Rose, et al. 1993. The Sukhumi primate monkey model for viral lymphomagenisis: high incidence of lymphomas with presence of STLV-I and EBV-like virus. Leukemia. 7(Suppl. 2):S86-92.
10. Ramer, J. C., R. L. Garber, K. E. Steele, et al. 2000. Fatal lymphoproliferative disease associated with a novel gammaherpesvirus in a captive population of common marmosets. Comp. Med. 50:59-68.
11. Luck, M. L., N. K. Laughlin, and D. R. Smith. 2000. Unpublished data.
12. Laughlin, N. K., R. E. Lasky, N. L. Giles, et al. 1999. Lead effects on neurobehavioral development in the neonatal rhesus monkey (Macaca mulatta). Neurotoxicol. Teratol. 21:627-638.
13. Rao, P., H. Jiang, and F. Wang. 2000. Cloning of the rhesus lymphocryptovirus capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections. J. Clin. Microbiol. 38:3219-3225.
14. Lerche, N. W., R. F. Cotterman, M. D. Dobson, et al. 1997. Screening for simian type-D retrovirus infection in macaques using nested polymerase chain reaction. Lab. Anim. Sci. 47:263-268.
15. Lerche, N. W., J. L. Yee, and M. B. Jennings. 1994. Establishing specific retrovirus-free breeding colonies of macaques: an approach to primary screening and surveillance. Lab. Anim. Sci. 44:217-221.
16. Ayscue, L. H., D. W. Ross, H. Ozer, et al. 1990. Bcr/abl recombinant DNA analysis versus karyotype in the diagnosis in the diagnosis and therapeutic monitoring of chronic myeloid leukemia. Am. J. Clin. Pathol. 94:404-409.
17. Rowe, J. M., and G. B. Segel. 1993. The leukemias, p. 455-485. In P. Rubin, S. McDonald, and R. Qazi (ed.), Clinical oncology: a multidisciplinary approach for physicians and students. W. B. Saunders Company, Philadelphia.
18. Vardiman, J. W. 1992. Chronic myelogenous leukemia and the myeloproliferative disorders, p. 1405-1438. In D. M. Knowles (ed.), Neoplastic hematopathology. Williams & Wilkins, Philadelphia.
19. Stone, R. M., and A. T. Skarin. 1996. Pathology and morphology of chronic leukemias and related disorders, p. 21-41. In P. H. Wiernik, G. P. Canellos, J. P. Dutcher, and R. A. Kyle (ed.), Neoplastic diseases of the blood. Churchill Livingstone, New York.
20. Canellos, G. P. 1996. Diagnosis and treatment of chronic granulocytic leukemia, p. 65-79. In P. H. Wiernik, G. P. Canellos, J. P. Dutcher, and R. A. Kyle (ed.), Neoplastic diseases of the blood. Churchill Livingstone, New York.
21. Castleberry, R. P., P. D. Emanuel, K. S. Zuckerman, et al. 1994. A pilot study of isoretinoin in the treatment of juvenile chronic myelogenous leukemia. N. Engl.J. Med. 331:1680-1684.
22. Gendron, A. 1999. Personal communication.
23. Goodnaugh, L. T., M. D. Monk, and G. L. Andride. 1997. Erythropoietin therapy. N. Engl.J. Med. 336:933-938.
24. Filip, S., J. Vanasek, M. Blaha, et al. 1997. Circulation of progenitor cells after intensive chemotherapy followed by combination G-CSF and EPO in breast carcinoma. Neoplasma 44:212-218.
25. Negrin, R. S., R. Stein, K. Doherty, et al. 1996. Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy. Blood 87:4076-4081.
26. Hellstrom-Lindberg, E., T. Ahlgren, V. Beguin, et al. 1998. Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients. Blood 92:68-75.
27. Emanuel, P. D., L. J. Bates, R. P. Castleberry, et al. 1991. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoetic progenitors. Blood 77:925-929.
28. Kuryrock, R., and M. Talpaz. 1996. Molecular biology of chronic leukemias, p. 81-105. In P. H. Wiernik, G. P. Canellos, J. P. Dutcher, and R. A. Kyle (ed.), Neoplastic diseases of the blood. Churchill Livingstone, New York.
29. Moghaddam, A., J. Koch, B. Annis, et al. 1998. Infection of human B lymphocytes with lymphocrptoviruses related to Epstein-Barr virus. J. Virol. 72:3205-3212.
30. Wang, F. 1999. Personal communication.
31. Schmutte, C., and R. Fishel. 1999. Genomic instability: first step to carcinogenesis. Anticancer Res. 19:4665-4696.
32. Winder, C., and T. Bonin. 1993. The genotoxicity of lead. Mutat. Res. 285:117-124.
33. Devi, K. D., B. S. Banu, P. Grover, et al. 2000. Genotoxic effect of lead nitrate on mice using SCGE (comet assay). Toxicology 145:195-201.
34. Ariza, M. E., and M. V. Williams. 1996. Mutagenesis of AS52 cells by low concentrations of lead (II) and mercury (II). Environ. Mol. Mutagen. 27:30-33.
35. Nakajima, T., T. Deguchi, K. Kagawa, et al. 1995. Identification of apoptotic hepatocytes in situ in rat liver after lead nitrate administration. J. Gastroenterol. 30:725-730.
36. Hartwig, A., R. Schlepegrel, and D. Beyersmann. 1990. Indirect mechanism of lead-induced genotoxicity in cultured mammalian cells. Mutat. Res. 241:75-82.
37. Ye, X. B., H. Fu, J. L. Zhu, et al. 1999. A study on oxidative stress in lead-exposed workers. J. Toxicol. Environ. Health 57:161-172.
38. Fu, H., and P. Boffetta. 1995. Cancer and occupational exposure to inorganic lead compounds: a meta-analysis of the published data. Occup. Environ. Med. 52:73-81.
39. Antilla, A., P. Heikkila, E. Pukkala, et al. 1995. Excess lung cancer among workers exposed to lead. Scand. J. Work Environ. Health. 21:460-469.
40. Gerhardsson, L. L., L. Hagman, L. Rylander, et al. 1995. Mortality and cancer incidence among secondary lead smelter workers. Occup. Environ. Med. 52:667-672.
41. Lundstrom, N. G., G. Nordberg, V. Englyst, et al. 1997. Cumulative lead exposure-relationship to mortality and lung cancer morbidity in a cohort of smelter workers. Scand. J. Work Environ. Health 23:24-30.
42. Farahati, J., E. P. Demidchik, J. Biko, et al. 2000. Inverse association between age at the time of radiation exposure and extent of disease in cases of radiation-induced childhood thyroid carcinoma in Belarus. Cancer 88:1470-1476.
43. Antilla, A., P. Heikkila, E. Nykyri, et al. 1996. Risk of nervous system cancer among workers exposed to lead. J. Occup. Environ. Med. 38:131-136.
44. Osterode, W., U. Barnabas, and K. Geissler. 1999. Dose dependent reduction of erythroid progenitor cells and inappropriate erythropoietin response in exposure to lead: new aspects of anaemia induced by lead. Occup. Environ. Med. 56:106-109.
45. Krugner-Higby, L., A. Rosenstein, L. Handshke, et al. Unpublished data.